All the Active Ingredient Drugs
Anticonvulsant. Lacosamide 50, 100, 150, 200 mg. F.C.TABS.: 14× 50mg
56 ×100mg/150mg/200mg
Dosage adjust. Individ accord. age and wt. of the pt.
Adolesc. child. & adult. wt. ≥50 kg: As monother.-The usual initiat. dose is 50,100 mg ×2/d, the dose may be incr. every wk. by 50 mg (admin. twice dly.) until you reach a mainten. dose between 100 mg and 300 mg×2/d.
In comb. with other antiepileptics:
The usual initiat. dose -50 mg ×2/d.
The dose may be incr. every wk. by 50 mg(admin. twice dly.) until you reach a mainten. dose between 100 mg and 200 mg ×2/d.
Pts. ≥50 kg: Lacosamide tmt. with a single load.dose of 200 mg. Starting ongoing mainten. dose 12 hrs. later.
Child. & adolesc.<50 kg: depends on bdy.wt. See lit.
Indicated as monother. and adjunct. ther. in the tmt. of partialonset seizures with/ without secondary generalization in pts. with epilepsy aged 4 yrs. and older.
C/I: Hypersens.
Pts. with 2nd or 3rd AV block.
Anticonvulsant. Lacosamide 50, 100, 150, 200 mg. F.C. TABS: 14, 56×50,100,150,200 mg.
Must be taken twice dly , recom. start.
dose is 50 mg ×2 dly. should be incr. to
an init. ther. dose of 100 mg ×2 dly
after one week. Depend. on response,
tolerab., the maint. dose can be further
incr. by 50 mg ×2 dly every week, to a
max. recom. dly dose of 400 mg (200
mg ×2 dly).
Adjunct. ther. in tmt. of part.-onset seiz. with/ without second. generaliz. in pts. with epilepsy aged 16 yrs and older.
C/I: Hypersens., known 2nd , 3rd –deg.
(AV) block.
